Literature DB >> 24595149

Intrathecal bupivacaine or levobupivacaine: which should be used for elderly patients?

Demet Gulec1, Bilge Karsli, Fatma Ertugrul, Zekiye Bigat, Nurten Kayacan.   

Abstract

OBJECTIVES: To compare two intrathecal anaesthetics, bupivacaine and levobupivacaine, for their effects on motor and sensory blockade and haemodynamics in patients aged ≥ 65 years undergoing transurethral resection of the prostate (TUR-P) or transurethral resection of the urinary bladder (TUR-M).
METHODS: Patients scheduled to undergo TUR-P or TUR-M were randomized to receive either 3 ml (15 mg) 0.5% isobaric levobupivacaine (group L) or 3 ml (15 mg) of 0.5% hyperbaric bupivacaine (group B) for spinal anaesthesia. The onset time, maximum level and time to reach the maximum level of sensory and motor blockade were recorded. Changes to haemodynamic parameters were also recorded.
RESULTS: The study randomized 100 patients: 57 to group L and 43 to group B. Levobupivacaine did not cause any significant changes in haemodynamic parameters, including systolic blood pressure, and showed a similar sensory block onset time compared with bupivacaine, but it had a significantly longer motor block onset time compared with bupivacaine.
CONCLUSION: These current findings suggest that levobupivacaine can be used as a substitute for bupivacaine for spinal anaesthesia in elderly patients ≥ 65 years of age undergoing elective TUR-P or TUR-M operations.

Entities:  

Keywords:  Elderly patients; bupivacaine; levobupivacaine; spinal anaesthesia; transurethral resection

Mesh:

Substances:

Year:  2014        PMID: 24595149     DOI: 10.1177/0300060513496737

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  2 in total

1.  Continuous thoracic spinal anesthesia with local anesthetic plus midazolam and ketamine is superior to local anesthetic plus fentanyl in major abdominal surgery.

Authors:  Paolo Vincenzi; Roberto Starnari; Lucia Faloia; Riccardo Grifoni; Roberto Bucchianeri; Leonardo Chiodi; Alfredo Venezia; Massimo Stronati; Marina Giampieri; Roberto Montalti; Diletta Gaudenzi; Lesley De Pietri; Gianfranco Boccoli
Journal:  Surg Open Sci       Date:  2020-07-17

2.  Bupivacaine in alginate and chitosan nanoparticles: an in vivo evaluation of efficacy, pharmacokinetics, and local toxicity.

Authors:  Cíntia Maria Saia Cereda; Daniel Sebbe Mecatti; Juliana Zampoli Boava Papini; Diego Valério Bueno; Michelle Franz-Montan; Thalita Rocha; José Pedrazzoli Júnior; Eneida de Paula; Daniele Ribeiro de Araújo; Renato Grillo; Leonardo Fernandes Fraceto; Silvana Aparecida Calafatti; Giovana Radomille Tofoli
Journal:  J Pain Res       Date:  2018-04-06       Impact factor: 3.133

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.